Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 5;14(12):2721. doi: 10.3390/pharmaceutics14122721

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Indications approved in Canada for biosimilars [132,133,134,135,136,137]. B-CLL = B-cell chronic lymphocytic leukemia; CD20 = cluster of differentiation 20; CHM = chemotherapy; CHOP = cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone; CVP = cyclophosphamide, vincristine, and prednisone; DLBCL = diffuse large B-cell non-Hodgkin lymphoma; EBC = early breast cancer; FN = febrile neutropenia; HER2 = human epidermal growth factor receptor 2; MBC = metastatic breast cancer; ML = myeloid leukemia; n-HL = non-Hodgkin lymphoma; NTP = neutropenia; PBPC = peripheral blood progenitor cell.